Tools & Calculators
Sector: Pharmaceuticals & Biotechnology
|Small Cap
Vivimed Labs Ltd.
₹8.43
₹8.07
₹8.43
₹6.72
₹29.40
Markets Today
Historical Performance
Indicator | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|
| Total Revenue | 18.66 | 17.94 | 22.58 | 34.23 | 22.16 |
| Operating Expense | 19.98 | 18.48 | 25.06 | 34.41 | 22.95 |
| Operating Profit | -1.32 | -0.54 | -2.48 | -0.18 | -0.79 |
| Depreciation | 4.68 | 4.80 | 4.61 | 6.37 | 3.86 |
| Interest | 1.60 | 0.52 | 1.48 | 0.43 | 0.37 |
| Tax | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -7.44 | -5.50 | -4.42 | -6.97 | -4.99 |
₹8.43
↗ Bullish Moving Average
9
↘ Bearish Moving Average
7
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 20.9 | 20.9 | 20.9 | 7.8 | 7.8 | 7.8 |
| FII | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 |
| DII | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Public | 77.3 | 77.3 | 77.3 | 90.5 | 90.5 | 90.5 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 2.42 L | 2.73 L | 88.43% |
| Week | 2.49 L | 4.05 L | 61.49% |
| 1 Month | 5.35 L | 7.45 L | 71.81% |
| 6 Month | 1.62 L | 2.25 L | 72.11% |
Positive Breakout Second Resistance ( LTP > R2)
Price crossing above SMA20 today, and greater than SMA5
Relative Outperformance versus Industry over 1 Year
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Effectively using its capital to generate profit - RoCE improving in last 2 years
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Stock gained more than 20% in one month
Stock with Low PE (PE < = 10)
Top Gainers
Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 19 Sep, 2018 | 0.4 | FINAL | Equity Share | |
| 21 Sep, 2017 | 0.4 | FINAL | Equity Share | |
| 24 Sep, 2014 | 3 | FINAL | Equity Share | |
| 24 Sep, 2013 | 3 | FINAL | Equity Share | |
| 21 Sep, 2012 | 3 | FINAL | Equity Share | |
| 26 Sep, 2011 | 2 | FINAL | Equity Share | |
| 09 Sep, 2010 | 1.5 | FINAL | Equity Share | |
| 24 Sep, 2009 | 1.5 | FINAL | Equity Share | |
| 22 Sep, 2008 | 1 | FINAL | Equity Share |
Financials | |||||
|---|---|---|---|---|---|
| Price (₹) | ₹104 | ₹115.35 | ₹604 | ₹791.10 | ₹690 |
| % Change | -1.38% | -3.98% | -1.99% | -2.37% | 3.06% |
| Revenue TTM (₹ Cr) | ₹282.74 | - | ₹488.20 | ₹588.52 | ₹1,496.96 |
| Net Profit TTM (₹ Cr) | ₹15.30 | - | ₹56.90 | ₹101.60 | ₹132.41 |
| PE TTM | 26.50 | - | 30.70 | 36.00 | 29.60 |
| 1 Year Return | -17.19 | 27.77 | 0.89 | 41.16 | -12.8 |
| ROCE | - | - | 23.87 | 9.34 | 14.12 |
Valiant Laboratories Ltd.
₹ 59.10
+1.37%
Sigachi Industries Ltd.
₹ 21.22
-3.68%
Windlas Biotech Ltd.
₹ 774.00
-0.82%
Vineet Laboratories Ltd.
₹ 31.51
-1.62%
Solara Active Pharma Sciences Ltd.
₹ 472.60
+0.23%
Zim Laboratories Ltd.
₹ 72.00
+1.72%
Medico Remedies Ltd.
₹ 48.00
+4.53%
Dishman Carbogen Amcis Ltd.
₹ 182.40
+0.07%
Lasa Supergenerics Ltd.
₹ 8.05
+2.42%
Advanced Enzyme Technologies Ltd.
₹ 313.00
+0.02%
Bajaj Healthcare Ltd.
₹ 348.00
-1.29%
Ortin Global Ltd.
₹ 18.91
-4.97%
Brooks Laboratories Ltd.
₹ 72.62
-2.48%
RPG Life Sciences Ltd.
₹ 1915.00
+0.59%
Bafna Pharmaceuticals Ltd.
₹ 111.50
-1.11%
Alpa Laboratories Ltd.
₹ 68.45
+2.30%
Sun Pharma Advanced Research Company Ltd.
₹ 127.75
-1.13%
SMS Pharmaceuticals Ltd.
₹ 375.20
+0.74%
Nectar Lifesciences Ltd.
₹ 12.70
+0.63%
Mangalam Drugs and Organics Ltd.
₹ 31.15
-1.61%
Indoco Remedies Ltd.
₹ 200.10
+0.93%
Ind-Swift Laboratories Ltd.
₹ 146.60
+3.32%
Lincoln Pharmaceuticals Ltd.
₹ 619.00
-0.58%
Panacea Biotec Ltd.
₹ 338.80
-0.79%
By signing up I certify terms, conditions & privacy policy